TITAN PHARMACEUTICALS INC (TTNP) Stock News
NASDAQ:TTNP - Nasdaq - US8883147055 - Common Stock - Currency: USD
TTNP Latest News, Press Relases and Analysis
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Titan Pharmaceuticals (NASDAQ:TTNP) just reported results for the second quarte...
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q2 2024
Titan Pharmaceuticals just reported results for the second quarter of 2024.
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q4 2023
Titan Pharmaceuticals just reported results for the fourth quarter of 2023.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, FRZA, TTNP on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IPXX, PWUP, DECA, TTNP on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders
TTNP Stock Earnings: Titan Pharmaceuticals Reported Results for Q1 2024
Titan Pharmaceuticals just reported results for the first quarter of 2024.
Shareholder Alert: Ademi LLP investigates whether Titan Pharmaceuticals, Inc. has obtained a Fair Price for its Public Shareholders
/PRNewswire/ -- Ademi LLP is investigating Titan (NASDAQ: TTNP) for possible breaches of fiduciary duty and other violations of law in its transaction with KE...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TTNP, MCRB, LLAP on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today announced that it has entered into a Merger and...
Titan pharmaceuticals notified of full compliance by NASDAQ (NASDAQ:TTNP)
Titan Pharmaceuticals, Inc. regains compliance with Nasdaq's bid price requirement, ensuring continued listing on The Nasdaq Capital Market.
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that...
Titan Pharmaceuticals to conduct 1-for-20 reverse stock split (NASDAQ:TTNP)
Titan Pharmaceuticals announces a 1-for-20 reverse stock split, with split-adjusted shares expected to trade on Nasdaq in January.
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
SOUTH SAN FRANCISCO, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that...